Compare CBLL & CION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | CBLL | CION |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Finance/Investors Services |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 428.8M | 513.6M |
| IPO Year | 2024 | N/A |
| Metric | CBLL | CION |
|---|---|---|
| Price | $20.91 | $10.19 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 5 | 1 |
| Target Price | ★ $24.20 | $8.50 |
| AVG Volume (30 Days) | ★ 582.1K | 333.9K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 14.61% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.49 |
| Revenue | $82,813,000.00 | ★ $244,923,000.00 |
| Revenue This Year | $37.43 | N/A |
| Revenue Next Year | $27.87 | N/A |
| P/E Ratio | ★ N/A | $20.74 |
| Revenue Growth | ★ 37.93 | N/A |
| 52 Week Low | $10.01 | $8.51 |
| 52 Week High | $32.75 | $12.71 |
| Indicator | CBLL | CION |
|---|---|---|
| Relative Strength Index (RSI) | 77.68 | 61.75 |
| Support Level | $19.87 | $9.62 |
| Resistance Level | $24.25 | $10.16 |
| Average True Range (ATR) | 1.12 | 0.18 |
| MACD | 0.33 | 0.02 |
| Stochastic Oscillator | 64.82 | 76.92 |
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.